Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07555418

Cell Suspension With Biologic Dressing for Burn Wounds

This study is a prospective, multicenter, real-world observational study. It aims to evaluate the effectiveness and safety of a combined therapy-autologous epidermal cell suspension followed by biological dressing (porcine xenograft) coverage-for wound repair after dermabrasion or surgical debridement in patients with second-degree burns. A total of 193 patients receiving the combined therapy will be enrolled from multiple hospitals across China. Their outcomes will be compared with 193 matched patients who received conventional treatment alone (e.g., xenograft alone, autologous skin grafting, or standard dressing changes). The primary outcomes include wound healing rate at 4 weeks and time to complete wound closure. Secondary outcomes include scar assessment, pigmentation, functional recovery, quality of life, and safety. Patients will be followed for up to 6 months.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Wound Healing

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with second-degree burn wounds requiring surgical dermabrasion or debridement and wound repair.
  • Age (No age restriction). For minors under 18 years, informed consent must be provided by a parent or legal guardian.
  • Stable vital signs and able to tolerate debridement and surgical procedures as confirmed by routine examinations.
  • Understand and willing to participate and able to provide signed informed consent.

Exclusion criteria

  • Severe uncontrolled systemic disease or acute systemic infection, or severe organ dysfunction (heart, lung, brain, etc.).
  • Psychiatric disorder that prevents compliance with treatment or follow-up.
  • Known allergy to porcine-derived materials or any component of the cell suspension preparation reagents.
  • Presence of diseases (e.g., autoimmune disease) or use of medications (e.g., high-dose immunosuppressants or corticosteroids) that may significantly affect wound healing.
  • HIV positivity, clinical diagnosis of AIDS, or absolute neutrophil count (ANC) < 1000 cells/mm³ during screening.

Treatment and study plan

Autologous Epidermal Cell Suspension

Procedure

A suspension of viable epidermal cells (including basal cells, epidermal stem cells, keratinocytes, melanocytes, and fibroblasts) isolated from a small sample of the patient's own skin. The suspension is sprayed onto the debrided wound bed to promote re-epithelialization.

Primary outcomes

  1. Wound Healing Rate at 4 Weeks

    Time frame: 4 weeks after treatment

    Proportion of wounds achieving complete epithelialization without drainage at 4 weeks post-treatment.

  2. Time to Complete Wound Healing

    Time frame: Up to 6 months

    Time to complete wound healing is defined as the number of days from initial treatment to complete wound closure (100% re-epithelialization).

Secondary outcomes

  1. Scar Assessment

    Time frame: Month 3, month 6

    Scar quality is evaluated using the Vancouver Scar Scale (VSS) or the Patient and Observer Scar Assessment Scale (POSAS), per site standard or investigator discretion.

    Scale specifications:

    VSS: Scores range from 0 to 13, where higher scores indicate worse scar outcome (0 = normal skin, 13 = worst possible scar).

    POSAS: Consists of Observer Scale (6 items: vascularity, pigmentation, thickness, relief, pliability, surface area) and Patient Scale (6 items: pain, itching, color, stiffness, thickness, irregularity). Each item is scored 1-10 (1 = normal skin/no complaint, 10 = worst imaginable). Total score ranges from 6 to 60. Higher scores indicate worse scar outcome.

  2. Pigmentation Assessment

    Time frame: Evaluation of hyperpigmentation or hypopigmentation in the healed wound area.

    Month 3, month 6

  3. Functional Recovery

    Time frame: Month 6

    Assessment of functional status of the healed area, including range of motion for wounds over joints.

  4. Quality of Life

    Time frame: Month 6

    Quality of life is assessed using a validated questionnaire, the Burn Specific Health Scale-Brief (BSHS-B).

    Scale specifications: The BSHS-B consists of multiple domains (e.g., physical function, psychological function, social function, general health, and work). Each item is scored on a 0-4 scale (0 = extreme problem, 4 = no problem). Domain and total scores are transformed to a 0-100 scale, where higher scores indicate better quality of life.

Other outcomes

  1. Incidence of Adverse Events

    Time frame: From enrollment to 6 months after treatment completion

    Proportion of participants experiencing local adverse reactions (erythema, edema, exudation, infection, rejection signs, rash, itching, allergy) or systemic adverse reactions (fever, systemic infection).

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital, Sun Yat-Sen University

Other

Registry information

Official study title

A Prospective, Multicenter, Real-World Observational Study of Autologous Epidermal Cell Suspension Combined With Biological Dressing for Wound Repair After Dermabrasion or Surgical Debridement in Patients With Second-Degree Burns

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Apr 29, 2026
Registry last updated
Apr 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.